FDA, EU Need Common Adverse Reaction Definitions, Lilly’s Simmons Says
Executive Summary
FDA and European regulators should adopt a common definition for what adverse reactions must be reported, Lilly Global Product Safety Advisor Valerie Simmons, MD, said
You may also be interested in...
Adverse Event Reports Should Be 80% Electronic By Year End, FDA Hopes
FDA hopes to receive 80% of adverse event reports in electronic format by the end of the year, CDER Division of Drug Risk Evaluation Associate Director Min Chen said
Adverse Event Reports Should Be 80% Electronic By Year End, FDA Hopes
FDA hopes to receive 80% of adverse event reports in electronic format by the end of the year, CDER Division of Drug Risk Evaluation Associate Director Min Chen said
FDA Drug Safety Rule Would Promote Premarketing Adverse Event Reports
FDA's proposed definition of "suspected adverse drug reactions" would encourage more premarketing adverse event reporting